Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted cancer therapies, including protein degraders and inhibitors. Its pipeline features drugs like SP-3164 and SP-2577, aimed at high unmet need cancers such as hematological malignancies and pediatric sarcomas. The company collaborates with academic institutions, holds key patents, and advances through regulatory pathways to bring innovative treatments to oncology markets.
This description was generated via AI from an annual report. Updated about 1 year ago.